Tobradex
Developed to alleviate ocular inflammation and to target bacterial infection in the eye.
Strengths: 0.1/0.3%
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Tobramycin and Dexamethasone Eye Drops
- Therapeutic class
Corticosteroid and Anti-infective
- Pharmacological class
Aminoglycoside and Corticosteroid
- Contraindications
viral, fungal, or tubercular eye infections; epithelial herpes simplex keratitis
- Minor side effects
eye discomfort; itching
- Moderate side effects
blurred vision; hyperaemia
- Dosage forms
Eye drops, suspension
- Administration route
Ocular use
- Prescription status
POM
- Manufacturer
Novartis
- Onset Time
minutes
- Duration
4–6 hours
- Storage instructions
Store upright below 25°C.
- Pregnancy and breastfeeding
Pregnancy: Avoid use. Breastfeeding: Discontinue during treatment.
Precautions and warnings
monitor intraocular pressure with prolonged use; discontinue if signs of sensitivity occur
Serious side effects
secondary ocular infection — requires immediate medical attention; glaucoma — requires immediate medical attention
Patient summary
Developed to alleviate ocular inflammation and to target bacterial infection in the eye.
Mechanism of action
Tobramycin inhibits bacterial protein synthesis; dexamethasone acts as a potent anti-inflammatory corticosteroid to reduce oedema and irritation.
Tobradex
Developed to alleviate ocular inflammation and to target bacterial infection in the eye.
Editorial Notes
- Active ingredient(s): Tobramycin, Dexamethasone
- Listed indication(s): Bacterial Conjunctivitis, Blepharitis